NCT05057013 2025-08-11A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursCancer Research UKPhase 1/2 Active not recruiting81 enrolled
NCT05919537 2025-04-18Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 MutationHummingbird BiosciencePhase 1 Active not recruiting68 enrolled
NCT04383210 2025-04-03Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsElevation OncologyPhase 2 Terminated54 enrolled 11 charts
NCT00730470 2010-07-29Phase I Study of U3P1287/01, Including Patients With Advanced Solid TumorsU3 Pharma GmbHPhase 1 Completed60 enrolled